A MONOCLONAL ANTIBODY TO CD44 FOR USE IN THE TREATMENT OF HEAD AND NECK SQUAMOUS CELL CARCINOMA

A MONOCLONAL ANTIBODY TO CD44 FOR USE IN THE TREATMENT OF HEAD AND NECK SQUAMOUS CELL CARCINOMA

A monoclonal anti-CD44 antibody, or antigen-binding fragment thereof, for use in the treatment of a head and neck squamous cell carcinoma (HNSCC) in a mammal, wherein said HNSCC is characterized by the expression of CD44. Said monoclonal antibody may be produced by the hybridoma deposited with the A...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DA CRUZ, LUIS A.G, FRANZMANN, ELIZABETH, JANE
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator DA CRUZ, LUIS A.G
FRANZMANN, ELIZABETH, JANE
description A monoclonal anti-CD44 antibody, or antigen-binding fragment thereof, for use in the treatment of a head and neck squamous cell carcinoma (HNSCC) in a mammal, wherein said HNSCC is characterized by the expression of CD44. Said monoclonal antibody may be produced by the hybridoma deposited with the ATCC with the accession number PTA-4621, and may be chimeric or humanized versions thereof.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SG182704A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SG182704A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SG182704A13</originalsourceid><addsrcrecordid>eNqFyzEKwkAQRuE0FqKewf8CgtGAacfdiQnu7mB2UliFIGslGoj3Rwt7q9d8b571BC9BjJNADhS0OYq9QgXGFgUqadFFRhOgNUNbJvUcFFKhZrLfwyKwOSNeOvLSRRh2DoZa0wTxtMxm9-ExpdWvi2xdsZp6k8ZXn6ZxuKVnevfxlJe7w7agfP9ffAADqjFn</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>A MONOCLONAL ANTIBODY TO CD44 FOR USE IN THE TREATMENT OF HEAD AND NECK SQUAMOUS CELL CARCINOMA</title><source>esp@cenet</source><creator>DA CRUZ, LUIS A.G ; FRANZMANN, ELIZABETH, JANE</creator><creatorcontrib>DA CRUZ, LUIS A.G ; FRANZMANN, ELIZABETH, JANE</creatorcontrib><description>A monoclonal anti-CD44 antibody, or antigen-binding fragment thereof, for use in the treatment of a head and neck squamous cell carcinoma (HNSCC) in a mammal, wherein said HNSCC is characterized by the expression of CD44. Said monoclonal antibody may be produced by the hybridoma deposited with the ATCC with the accession number PTA-4621, and may be chimeric or humanized versions thereof.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20120830&amp;DB=EPODOC&amp;CC=SG&amp;NR=182704A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20120830&amp;DB=EPODOC&amp;CC=SG&amp;NR=182704A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DA CRUZ, LUIS A.G</creatorcontrib><creatorcontrib>FRANZMANN, ELIZABETH, JANE</creatorcontrib><title>A MONOCLONAL ANTIBODY TO CD44 FOR USE IN THE TREATMENT OF HEAD AND NECK SQUAMOUS CELL CARCINOMA</title><description>A monoclonal anti-CD44 antibody, or antigen-binding fragment thereof, for use in the treatment of a head and neck squamous cell carcinoma (HNSCC) in a mammal, wherein said HNSCC is characterized by the expression of CD44. Said monoclonal antibody may be produced by the hybridoma deposited with the ATCC with the accession number PTA-4621, and may be chimeric or humanized versions thereof.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFyzEKwkAQRuE0FqKewf8CgtGAacfdiQnu7mB2UliFIGslGoj3Rwt7q9d8b571BC9BjJNADhS0OYq9QgXGFgUqadFFRhOgNUNbJvUcFFKhZrLfwyKwOSNeOvLSRRh2DoZa0wTxtMxm9-ExpdWvi2xdsZp6k8ZXn6ZxuKVnevfxlJe7w7agfP9ffAADqjFn</recordid><startdate>20120830</startdate><enddate>20120830</enddate><creator>DA CRUZ, LUIS A.G</creator><creator>FRANZMANN, ELIZABETH, JANE</creator><scope>EVB</scope></search><sort><creationdate>20120830</creationdate><title>A MONOCLONAL ANTIBODY TO CD44 FOR USE IN THE TREATMENT OF HEAD AND NECK SQUAMOUS CELL CARCINOMA</title><author>DA CRUZ, LUIS A.G ; FRANZMANN, ELIZABETH, JANE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SG182704A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2012</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>DA CRUZ, LUIS A.G</creatorcontrib><creatorcontrib>FRANZMANN, ELIZABETH, JANE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DA CRUZ, LUIS A.G</au><au>FRANZMANN, ELIZABETH, JANE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>A MONOCLONAL ANTIBODY TO CD44 FOR USE IN THE TREATMENT OF HEAD AND NECK SQUAMOUS CELL CARCINOMA</title><date>2012-08-30</date><risdate>2012</risdate><abstract>A monoclonal anti-CD44 antibody, or antigen-binding fragment thereof, for use in the treatment of a head and neck squamous cell carcinoma (HNSCC) in a mammal, wherein said HNSCC is characterized by the expression of CD44. Said monoclonal antibody may be produced by the hybridoma deposited with the ATCC with the accession number PTA-4621, and may be chimeric or humanized versions thereof.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_SG182704A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title A MONOCLONAL ANTIBODY TO CD44 FOR USE IN THE TREATMENT OF HEAD AND NECK SQUAMOUS CELL CARCINOMA
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T22%3A26%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DA%20CRUZ,%20LUIS%20A.G&rft.date=2012-08-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESG182704A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true